"GPT-Rosalind is designed to support evidence synthesis, hypothesis generation, experimental planning, and multi-step scientific workflows across biochemistry, genomics, and protein engineering."
"The model is named after Rosalind Franklin, whose diffraction imaging of DNA was instrumental in revealing the double helix structure, highlighting her contributions to molecular biology."
"OpenAI is framing GPT-Rosalind as a tool to compress the timeline from scientific idea to clinical evidence, currently estimated to take 10 to 15 years for drug development."
GPT-Rosalind is OpenAI's first domain-specific model series, fine-tuned for biochemistry, genomics, and protein engineering. It supports evidence synthesis, hypothesis generation, and experimental planning. Access is limited to vetted enterprise customers like Amgen and Moderna. Named after Rosalind Franklin, the model acknowledges her foundational contributions to molecular biology. OpenAI aims to reduce the timeline from scientific idea to clinical evidence, addressing the lengthy process of drug development, which currently takes 10 to 15 years in the U.S.
Read at TNW | Artificial-Intelligence
Unable to calculate read time
Collection
[
|
...
]